Intravenous vs intrathecal transplantation of allogeneic GMP/GCP compliant Wharton’s jelly mesenchymal stromal cells in ALS patients: a phase I study

In conclusion, using WJ-MSCs is safe and feasible in ALS patients, but the efficacy of these cells should be assessed in future studies with more patients, different routes of cell administration, and maybe with higher doses of the injected cells.